Status: Recruiting
Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
This prospective study aims to evaluate the sensitivity and specificity of an integrated model using fragmentomic profiles of plasma cell-free DNA for early detection of pancreatic neuroendocrine tumors and differential diagnosis of solid pancreatic tumors.
Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fudan UniversityUpdated: Mar 25, 2026Locations: 2
Eligibility criteria
Age 18 and above, regardless of gender; [+5]
Pathological diagnosis was not pancreatic neuroendocrine tumor, pancreatic ducta... [+8]